Law360, New York (March 28, 2011, 2:27 PM ET) -- With the fate of his attorney still pending before the First Circuit, the representative of a consumer class allegedly overcharged for chemotherapy drugs lodged a last-ditch attempt Friday to disqualify the lead class counsel and kill a proposed settlement agreement.
Counsel in the average wholesale price multidistrict litigation could have signed off on a 2007 settlement deal that would have delivered $13 million to a class of Medicare beneficiaries who bought allegedly overpriced chemotherapy drugs through Bristol-Myers Squibb Co., according to a motion to disqualify those...
Class Rep Pushes To Kill Deal Over Chemo Drug Sales
To view the full article, take a free trial now.
